The aim of this study was to conduct a quantitative review of prostate cancer studies to pool relative risk (RR) estimates on the association between prostate cancer and vasectomy, in an attempt to determine whether there is an association, and if so, its magnitude. Random-effects models were examined along with a linear model for time since vasectomy. The pooled RR estimate was 1.37 (95% CI ¼ 1.15 -1.62) based on five cohort studies and 17 case -control studies. The RR estimate varied by study design with the lowest risk for population-based casecontrol studies. No difference was seen in risk by age at vasectomy. A linear trend based on the 16 studies reporting time since vasectomy suggested an 10% increase for each additional 10 y or a RR of 1.32 (95% CI ¼ 1.17 -1.50) for 30 y since vasectomy. When null effects were assumed for the six studies not reporting information, the linear RR for the 22 studies was 1.07 (1.03 -1.11) and 1.23 (1.11 -1.37) for 10 and 30 y since vasectomy, respectively. These results suggest that men with a prior vasectomy may be at an increased risk of prostate cancer, however, the increase may not be causal since potential bias cannot be discounted. The overall association was small and therefore could be explained by bias. The latency effect shown here for time since vasectomy should be examined further.
Introduction
Since vasectomy is a common birth control method and prostate cancer is a common malignancy of significant public health interest, a better understanding of how they are related is important. The estimated 189 000 new cases of prostate cancer expected in the year 2002 reflect a disease affecting one in every six men. 1 Prevalence rates of vasectomy range from 7 to 8% in China and India, to 23% in New Zealand, with prevalence in the USA at about 11%. 2 The percentage of US men with vasectomies was 11% in 1995 as it was in 1982. 3 Any association between vasectomy and prostate cancer could therefore affect a large percentage of men.
Several studies have found a positive association between vasectomy and increased risk of prostate cancer, while a few others have failed to identify any relationship. There have been several reviews of this association. The review by DerSimonian et al 4 examined six studies published from January 1970 through to December 1991, but did not include a 1991 update 5 of an earlier study. 6 A more recent review by BernalDelgado et al 7 of studies published from January 1985 through to December 1996 did not include all studies published during that period. 8, 9 It is unclear if the excluded studies were random. Neither of these reviews examined time since vasectomy; a third review examined time since vasectomy, but was confined to seven studies, one of which was later excluded. 10 Schwingl and Guess 3 also report a slightly elevated risk based upon pooling of results from five case -control and six registry or cohort studies in the context of a broader review of the safety and effectiveness of vasectomy. A reconsideration of these questions, incorporating all published studies, may be less subject to reviewers bias than excluding studies without justification.
The purpose of this study was to apply a detailed meta-analytic approach for combining relative risk estimates from studies on the relationship between prostate cancer incidence and vasectomy to estimate the effect size of the relative risk (RR) estimate, to examine the possible effects of time since vasectomy, and to consider for the first time in the context of a meta-analysis the effect of age at time of vasectomy.
Materials and methods
MEDLINE and CANCERLIT automated citation files were searched using key words among articles published from 1966 to June 2001. MESH headings, key words and text words searched on included: prostate cancer, vasectomy, and risk factors. These articles were gathered, then references listed in each article were checked for additional relevant studies. This search was repeated until no additional articles were found prior to June 2001. References in commentaries on vasectomy were used as an additional source of potential studies.
Out of 107 articles identified through MEDLINE, we found 31 reviews, 16 non-research letters, 17 commentaries, 24 analytic studies of prostate cancer and vasectomy and 19 other articles. We gathered the 24 analytic articles, including one research letter, and checked their references for additional relevant studies. In an attempt to identify some 'unpublished' RR estimates for prostate cancer and vasectomy, we examined additional articles of reporting sexual activity. An additional eight articles were identified using these methods. Of the 32 articles reviewed in detail, six were determined to have no relevant data. Of the relevant 26 articles, four publications appeared to be on populations already reported, leaving 22 independent studies.
The studies considered in this meta-analysis were case -control studies or cohort studies that assessed vasectomy status. The data were abstracted by two of three independent reviewers (LKD, DVD, MIR) and included information available on the RR, 95% CIs, and cell counts of cases and controls by exposure. Two sets of results were compared for accuracy and re-reviewed if necessary. Third party resolution of disagreements was sought when needed. Variances for studies were calculated based on the reported confidence intervals. When confidence intervals were not reported, the variance was estimated from the reported data. If studies indicated that vasectomy was examined and no association with prostate risk was found, but no RR was reported then those studies were assigned a RR estimate of 1.0. We estimated corresponding variances based on the number of subjects assuming an average exposure rate calculated from the other studies. Pooled RRs were estimated by both the fixed effects model and the random effects model for pooling RR estimates and their variances. 11, 12 The random effects model is more appropriate when studies are heterogeneous or if there is reason to believe publication bias exists. Homogeneity among the studies was assessed. Funnel plots were used to examine whether or not the pattern of reported results was random or varied by sample size. Studies were pooled for vasectomy: by study design, location of population, and study period. Age at vasectomy, characterized as performance of vasectomy before the age of 40 and after age 40 was examined as a potential effect modifier. Time since vasectomy was examined for the presence of a linear relationship with prostate cancer risk for each study where feasible.
A linear association was examined for time since vasectomy using a covariance adjusted technique. 13, 14 For one of the studies, data was not available for covariance adjustment. Since several studies (six of 22) did not report information on time since vasectomy and limited response could be secured from the original authors, studies not reporting information were first excluded from the meta-analyses addressing linear effects of time since vasectomy. Data were then re-analyzed including these six studies but assuming that there was no association found (a linear RR of 1.0). For those six studies, the variances needed for the linear model in the meta-analysis were estimated based upon the mean ratio of the variance of the linear effect and the vasectomy status variance obtained from the other 16 studies, multiplied by the vasectomy status variance appropriate to that particular study. This should give a conservative estimate, since it may tend to underestimate these quantities. Throughout, if raw data were used to calculate the RR because RRs were not stated in a particular report, no adjustment was made for covariates; otherwise, reported covariate-adjusted RRs were used.
Results
Several publications were found to have used the same study population. Only the most complete or recent publication was included in the meta-analysis. Five studies of prostate cancer not published in English were examined but none of them reported information on vasectomy. Three publications were based on the Kaiser Permanente Medical Care Program of Northern California among men receiving a multiphasic health checkup. 15 -17 The 1991 publication 15 was an update of the earlier report, 16 so only the more recent publication 15 was used. It was unclear if the Sidney et al 15 and the Hiatt et al 17 studies included the same subjects. They appeared to have some overlap. The meta-analysis was examined including both studies and only the Sidney et al 15 study, since it had two more years of data. The study by Newell et al 7 reported no association; however, the review by DerSimonian et al 4 reported an odds ratio (OR) of 1.5 (95% CI 0.8 -2.9) based on personal communication with the authors. The OR reported by DerSimonian et al 4 for the Newell study was used in this meta-analysis.
Cohort and case -control studies that examined the risk of prostate cancer with prior vasectomy are reported in Table 1 . 5,6,8 -10,15 -34 The duplicate publications are italicized and indented below the publication used in the meta-analysis. The study details are described in Table 1 . After removing all the duplicate publications, five studies used in the meta-analysis reported results for cohort studies and 17 were case -control studies (Table 1) . One study used neighborhood, cancer, and other hospital controls but only the risk based on population (neighborhood) controls was used in the meta-analysis. This left nine of the case -control studies using population-based controls and seven with hospital-based (cancer, heart disease, and other hospital controls) control groups. Age was controlled for in each study by matching, frequency matching or statistically adjusting for age.
The studies appeared to be heterogenous (P < 0.0001) based upon Woolf's 11 test for heterogeneity of RR. Since the studies are measuring different populations at risk, a random effects model was used. The random effects model is more appropriate than a fixed effects model when heterogeneity exists. 12 The results of the metaanalysis for vasectomy based on random effects models are also reported in Table 1 by study design. Due to the heterogeneity studies were only pooled within similar study designs, eg cohort studies and case -control studies based on their recruitment of controls as populationbased or hospital-based. The RR estimates and their 95% confidence intervals (CI) along with the pooled estimates within each study design are plotted in Figure  1 . This gives a graphical representation of the distribution of the estimates.
Overall, the pooled estimate of the RR was 1.37 (95% CI of 1.15 -1.62) based on 22 studies in a random effects model. Due to the large heterogeneity seen this should be interpreted with caution. When the Hiatt et al 17 study was combined with the cohort studies along with the Sidney study, 15 the association was reduced from a RR of 1.22 to a RR of 1.14. However, this probably over-represents the Northern Californian Kaiser Permanente population for 1978 -1982 in the meta-analysis. The pooled estimate among the least biased study design, cohort studies, was RR ¼ 1.22 (95% CI of 0.90 -1.64).
Among the 22 studies, nine stratified the association by age at vasectomy. Using the fixed effects approach, the pooled association for age at vasectomy under the age of 40 was 1.14 (95% CI of 0.99 -1.31) for these homogeneous studies, while the pooled estimate for vasectomy at age 40 or older was RR ¼ 1.17 (95% CI of 1.00 -1.35). The random effects and fixed effects models yielded similar results, with slightly wider confidence intervals obtained using the random effects approach. This is due to the conservative nature of the DerSimonian and Laird method. 12 These results suggest no difference in prostate cancer by age at vasectomy. Table 2 provides results for the meta-analysis addressing a linear association of prostate cancer with time since vasectomy. Since a linear response in the lnRR was assumed, the RR was calculated for three levels of time. Given that most vasectomies are performed on men in their 30s and the mean age at diagnosis of prostate cancer is 70, 1, 3 we estimated time since vasectomy for 20, 30 and 40 y. The first analysis, in Table 2 , evaluating this linear effect utilized only the 16 studies reporting information on time since vasectomy. The linear models were covariate adjusted except for one study with no reported crude cells, 15 however, covariance adjustment made little difference in the estimate or its variance. Strong linear effects were seen among the three cohort studies and the six hospital-based studies. For the 16 studies, the RR for 20 and 30 y since vasectomy were 1.21 (95% CI of 1.11 -1.31) and 1.32 (95% CI of 1.17, 1.50), respectively. Figure 2 shows the RRs for 20 y since vasectomy for each study.
Six of the 22 studies did not report detailed information other than vasectomy status. Since only the three significant cohort studies reported detail on time since vasectomy, it was feared that this represented a form of publication bias. Therefore, we also performed a metaanalysis in which the six studies not reporting time since vasectomy were pooled with the other studies assuming a null effect and estimating the variance. Assuming a null effect (linear RR of 1.0) for the six studies should give an estimate of the lower limit of the linear estimates. Including the six assumed null effects reduced the point estimates, but the RR for 30 y since vasectomy remained significant, 1.23 (95% CI of 1.11, 1.37).
In an attempt to examine potential biases, we stratified the association by study design, location of the study population, stage of disease, publication year of the article, and diagnosis dates of prostate cancer cases defined as before prostate specific antigen (PSA) screening if the mid-year of case collection was prior to 1990. Table 3 compares each of these stratifications. Minimal differences were seen by publication year and prostate cancer case collection period. A higher RR estimate was seen in non US populations than in US populations.
Discussion
The overall pooled result for all study designs of prostate cancer and vasectomy status was significant at 1.4 (95% CI of 1.1, 1.6). No effect modification by age at vasectomy was seen among the nine studies reporting age at vasectomy. However, an effect was seen with time since vasectomy. Potential bias is of concern and may account for such a small association.
The results seen here among 16 studies for time since vasectomy (RR ¼ 1.32 after 30 y) were not as strong as those reported by Giovannucci et al 10 in their consideration of the six initial reports of this possible linear association (RR ¼ 2.03 after 30 y). However, a significant effect was still seen for prostate cancer with stronger effects seen among cohort studies (RR ¼ 1.82 after 30 y) and hospital-based case-control studies (RR ¼ 2.28 after 30 y). The effect persisted even after inclusion of the studies not reporting time since vasectomy, assuming that no association was present (eg a linear RR of 1.0). Time since vasectomy is directly correlated with age. Based on three surveys of the age at which men who elect to have a vasectomy do so, it appears that 25% do so before age 30, 50 -75% at age 30 -39, and 5 -25% at ages 40 -44. 3 With a mean age of prostate cancer at age 70, even with no association with vasectomy, we would expect to see men with a vasectomy diagnosed with prostate cancer 30 -40 y after their vasectomy. Many of the studies reviewed appeared to include younger men at Other studies included three studies with cancer controls, one study with heart disease controls (a mortality-based study) and three other hospital-based controls.
reduced risk of prostate cancer, possibly biasing the RR estimate towards 1.0. Each study attempted to adjust for effects of age by matching or controlling for age in their analyses. If they did not completely adjust for age in their analyses of time since vasectomy, then residual confounding due to age could account for the association seen with time since vasectomy. The variation seen by study design might also suggest bias in the risk estimates. Non-differential reporting of vasectomy which would bias any effect towards the null, is also less likely here than in studies of more subjective exposures. Possible sources of selection or confounding bias among men with vasectomies is less clear and the direction of such an influence is unknown. It is unclear what form of selection bias or referral bias would produce a reduced prevalence of vasectomy in hospital-based controls to inflate the RR estimate to 1.9. If men with vasectomies are utilizing health care systems more frequently than other men for decades after their vasectomy, this would suggest a detection bias. A detection bias between vasectomy and prostate cancer would suggest that vasectomized men may be over-represented in hospital-based control Figure 1 Relative risk estimate (RR) for prostate cancer and vasectomy status for each original study and pooled estimates overall and by study design.
Vasectomy and the risk of prostate cancer LK Dennis et al Figure 2 Relative risk estimate (RR) for prostate cancer and 20 y since vasectomy for each original study and pooled estimates overall and by study design. Hospital-based studies included four studies with cancer controls, one study with heart disease controls (a mortality-based study) and three other hospital-based controls. b Of the 16 studies that reported detailed information on the time since vasectomy, the average variance for vasectomy status was 0.072 and the average variance for time since vasectomy was 0.00025. The average ratio of these was 0.0023 and multiplied by the variance for vasectomy status in the each of the six studies not reporting time since vasectomy to estimate their variance.
groups. These data do not support over-representation of vasectomy in hospital-based controls since such a bias would artificially decrease the RR among hospital-based studies. The greatest detection bias would be expected at times closer to when the vasectomy was performed which is unlikely because these men are too young. The increased risk seen here with longer times since vasectomy does not support such a detection bias. Additionally, if health conscious behavior is related to vasectomy status, this could produce a screening bias that might over-represent men with vasectomies in early stage cancers due to their screening behavior. 28 Such an effect would create a detection bias among these men. Twenty-seven per cent of surveyed urologists report screening men with vasectomies earlier for prostate cancer. 3 A recent large population-based case-control study found higher RR estimates for vasectomy among earlier stages at diagnosis than for more advanced stages. 28 They further found that vasectomized men were less likely to have symptoms at diagnosis. 28 The higher association seen in non-US studies may be related to a higher vasectomy rate in countries other than the USA. Among the seven non-US studies, the strongest association was seen in the two population-based casecontrol studies (RR > 6.0). No association was seen in either cohort study while the hospital-based case-control studies varied in risk (0.7 < RR < 2.6).
It is difficult to speculate on the potential bias due to confounding, because relatively few risk factors have been identified for this disease. Most studies adjusted for age, but none adjusted for sexual activity. Since an increased number of sexual partners and history of a sexually transmitted infection (STI) appear to be related to prostate cancer 9, 17, 21, 22, 35 but likely inversely related to having a vasectomy, this would cause negative confounding. The potential negative confounding would suggest that the pooled RR reported here is underestimated. Infections have been reported at higher rates in men with prostate cancer. 17, 35 Infections could positively confound the association between prostate cancer and vasectomy status if men with vasectomies were more prone to infections than other men. However, Schwingl and Guess 3 suggest that complications and infections soon after vasectomy occur in 6% or less of men. Less is known about how circulating immune complexes, which occur after vasectomy, may effect the prostate. Vasectomy may be a marker for such factors, or some other as yet unidentified causative factor for prostate cancer.
Since the positive association seen between prostate cancer and vasectomy status in these pooled results is largely due to effects seen among hospital-based casecontrol studies, recall bias is unlikely. In retrospective studies, some exposures are more likely to be reported by diseased individuals who may be thinking about potential causes of their disease, than by populationbased controls. Such a bias is often referred to as recall bias which is more likely in population-based case -control studies, since hospital controls may be more similar to cases in trying to recall exposures prior to their disease. Recall bias would be reflected in a higher RR among population-based studies than hospital-based control groups. Recall bias of vasectomy is less likely to occur than recall bias of more subjective exposures. Recent studies have reported that 99 -100% of self-reported vasectomies were confirmed in substudies. 27, 28 Combined with the results seen here, we see no evidence of recall bias.
Publication bias is another potential problem when combining studies in a meta-analysis. There is evidence that in general, studies with positive results are more likely to be published than studies with negative results. 36, 37 Funnel plots can be used to examine whether or not the pattern of reported results was random or varied by sample size. The expectation is that smaller studies with negative results or no effect are less likely to get published. The funnel plot analyses of prostate cancer and vasectomy (not shown) did not reveal evidence for publication bias for large standard errors (small sample size) with null or negative findings. Due to the importance of a potential association or lack there of between prostate cancer and vasectomy, publication bias may occur less frequently than with other associations. The biological mechanism through which vasectomy may be related to prostate cancer is not well understood. Theories include changes in endocrine status, alterations in immunity, change in the prostate exposure to growth factors and/or inhibitors, or a decrease in factors that inhibit malignant growth. 38 While major changes in hormone profiles probably do not occur after vasectomy, more subtle alterations may occur. 23 Short term effects of vasectomy on the endocrine and immunological systems and prostate physiology have been studied, however long-term effects are unclear. 23 Studies have shown morphological changes in the testicles following vasectomy. 39, 40 The histological changes following vasectomy were not directly related to antisperm antibody status, suggesting some other pathophysiologic process. 40 While unlikely, it is possible such changes in the testicle may be a factor in prostate cancer initiation.
An association between a high incidence cancer such as prostate cancer with a moderately prevalent condition such as vasectomy is a concern due to the potential number of men affected. Assuming the pooled RR estimate of 1.22 based on the cohort studies is unbiased we can estimate the amount of the population affected by this association given an annual prostate cancer incidence of 147 per 100 000 men based on 1993 -1997 SEER data 41 and the fact that 11% of US men have had a vasectomy. 3 These data suggest that the incidence of prostate cancer due to vasectomy among men with vasectomies is 32 per 100 000 men or 18% of prostate cancer among vasectomized men is attributable to vasectomy with a population attributable risk per cent of 2.4%.
Limitations
As in any other type of study, the meta-analyst must recognize the limitations of the data and the techniques being used. The information in each article is assumed to be accurate and reliable. Meta-analysis cannot transcend the limitations of the studies upon which it is based. 42 The data pooled in these analyses is limited in that it cannot directly address potential selection bias of subjects, screening bias or other potential bias due to confounding in the original studies.
Conclusions
The pooled analyses suggest a small association between vasectomy status and prostate cancer risk. Such a small RR could be accounted for by bias. With limited evidence, a biological mechanism supporting a relationship between vasectomy and prostate cancer seems unlikely. The association should be re-examined when more is known about potential risk factors for prostate cancer that may confound the association with vasectomy.
